10.1002/ejoc.201700754
European Journal of Organic Chemistry
(E)-2,2'-(3-((Tetrahydro-2H-pyran-2-yl)oxy)prop-1-ene-1,2-
diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (15a)12: H NMR (500
83.8, 24.6, -2.1; 11B NMR (160 MHz, CDCl3): 30.5; HRMS (ESI-Orbit
trap) m/z: [M+H]+ calcd for C27H31BO2Si+H, 427.2265; found 427.2260.
(E)-Trimethyl(2-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)vinyl)silane (1d): 1H NMR (500 MHz, CDCl3): 7.40-7.37 (m, 2H), 7.30-
7.19 (m, 3H), 6.72 (br s, 1H), 1.33 (s, 12H), 0.21 (s, 9H); 13C NMR (125
MHz, CDCl3): 150.6, 145.6, 128.0, 126.9, 126.7, 83.8, 25.1, 0.3; 11B NMR
(160 MHz, CDCl3): 30.2; HRMS (ESI-Orbit trap) m/z: [M+H]+ calcd for
C17H27BO2Si+H, 303.1952; found 303.1950.
1
MHz, CDCl3): 6.14 (br s, 1H), 4.65 (m, 1H), 4.38 (dd, J1 = 14.5 Hz, J2 =
2.0 Hz, 1H), 4.10 (dd, J1 = 14.5 Hz, J2 = 1.5 Hz, 1H), 3.87-3.82 (m, 1H),
3.49-3.45 (m, 1H), 1.89-1.81 (m, 1H), 1.72-1.50 (m, 5H), 1.30 (s, 12H),
1.27 (s, 12H); 13C NMR (125 MHz, CDCl3): 97.5, 83.8, 83.4, 71.6, 61.5,
30.4, 25.5, 24.9, 24.9, 24.8, 19.0.
(1,2-bis(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-
1
yl)vinyl)trimethylsilane (16a): E-isomer18a. H NMR (500 MHz, CDCl3):
(E)-Trimethyl(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(p-
6.59 (s, 1H), 1.33 (s, 12H), 1.26 (s, 12H), 0.09 (s, 9H); 13C NMR (125 MHz,
tolyl)vinyl)silane (2d): H NMR (500 MHz, CDCl3): 7.30 (d, J = 8.0 Hz,
1
CDCl3): 83.5, 83.5, 25.2, 24.9, -1.5; 11B NMR (160 MHz, CDCl3): 32.0. Ζ-
2H), 7.10 (d, J = 8.0 Hz, 2H), 6.70 (s, 1H), 2.33 (s, 3H), 1.33 (s, 12H), 0.21
(s, 9H); 13C NMR (125 MHz, CDCl3): 149.4, 142.7, 136.4, 128.7, 126.8,
83.8, 25.1, 21.1, 0.3; 11B NMR (160 MHz, CDCl3): 30.4; HRMS (ESI-Orbit
trap) m/z: [M+H]+ calcd for C18H29BO2Si+H, 317.2108; found 317.2102.
(E)-(2-(4-Fluorophenyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
1
isomer: H NMR (500 MHz, CDCl3): 7.03 (s, 1H), 1.25 (s, 12H), 1.24 (s,
12H), 0.17 (s, 9H); 13C NMR (125 MHz, CDCl3): 83.4, 83.3, 24.9, 24.7,
0.3; 11B NMR (160 MHz, CDCl3): 28.9.
(Z)-1,2-Diphenyl-1,2-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
1
1
yl)ethene (17a)12: H NMR (500 MHz, CDCl3): 7.07-7.01 (m, 6H), 6.96-
yl)vinyl)dimethyl(phenyl)silane (3b): H NMR (500 MHz, CDCl3): 7.60-
6.93 (m, 4H), 1.32 (s, 24H); 13C NMR (125 MHz, CDCl3): 141.2, 129.3,
7.57 (m, 2H), 7.42-7.39 (m, 2H), 7.35-7.32 (m, 3H), 6.93-6.89 (m, 2H),
6.83 (s, 1H), 1.16 (s, 12H), 0.48 (s, 6H); 13C NMR (125 MHz, CDCl3):
162.2 (d, JC-F = 244.0 Hz), 147.8, 141.2, 140.9 (d, JC-F = 3.0 Hz), 133.8,
128.6, 128.6 (d, JC-F = 8.0 Hz), 127.6, 114.7 (d, JC-F = 21.0 Hz), 83.9, 24.8,
-0.6; 11B NMR (160 MHz, CDCl3): 29.7; HRMS (ESI-Orbit trap) m/z:
[M+H]+ calcd for C22H29BFO2Si+H, 383.2014; found 383.2009.
127.4, 125.8, 84.0, 24.9.
(Z)-2,2'-(Hex-3-ene-3,4-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (18a)18a: 1H NMR (500 MHz, CDCl3): 2.21 (q, J = 7.5 Hz,
4H), 1.29 (s, 24H), 0.97 (t, J = 7.5 Hz, 6H); 13C NMR (125 MHz, CDCl3):
83.3, 24.9, 23.6, 14.3.
(Z)-2,2'-(Dec-5-ene-5,6-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (19a)20: H NMR (500 MHz, CDCl3): 2.19-2.16 (m, 4H),
(E)-(2-(4-Fluorophenyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
1
1
yl)vinyl)(methyl)diphenylsilane (3c): H NMR (300 MHz, CDCl3): 7.62-
1.38-1.30 (m, 8H), 1.28 (s, 24H), 0.88 (t, J = 7.5 Hz, 6H); 13C NMR (125
7.34 (m, 12H), 7.06-6.99 (m, 3H), 1.02 (s, 12H), 0.87 (s, 3H); 13C NMR (75
MHz, CDCl3): 162.3 (d, JC-F = 244.5 Hz), 145.6, 140.9 (d, JC-F = 3.0 Hz),
138.7, 134.6, 128.9, 128.7 (d, JC-F = 8.0 Hz), 127.4, 114.9 (d, JC-F = 21.0
Hz), 84.0, 24.6, -2.1; 11B NMR (160 MHz, CDCl3): 30.3; HRMS (ESI-Orbit
trap) m/z: [M+H]+ calcd for C27H30BFO2Si+H, 445.2170; found 445.2166.
(E)-Methyldiphenyl(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
MHz, CDCl3): 83.2, 32.0, 30.5, 24.9, 23.0, 14.0.
(Z)-2,2'-(Hept-2-ene-2,3-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
1
dioxaborolane) (20a): H NMR (500 MHz, CDCl3): 2.18 (t, J = 7.5 Hz,
2H), 1.74 (s, 3H), 1.36-1.30 (m, 4H), 1.28 (s, 12H), 1.27 (s, 12H), 0.88 (t, J
= 7.5 Hz, 6H); 13C NMR (125 MHz, CDCl3): 83.3, 83.2, 31.1, 30.8, 24.9,
24.8, 23.0, 15.9, 14.0; 11B NMR (160 MHz, CDCl3): 30.8; HRMS (ESI-
Orbit trap) m/z: [M+H]+ calcd for C19H36B2O4+H, 351.2878; found
351.2874.
1
yl)hept-1-en-1-yl)silane (5c): H NMR (500 MHz, CDCl3): 7.55-7.52 (m,
4H), 7.33-7.28 (m, 6H), 6.57 (s, 1H), 2.32 (t, J = 7.5 Hz, 2H), 1.49-1.26 (m,
6H), 0.95 (s, 12H), 0.90 (t, J = 7.5 Hz, 3H), 0.74 (s, 3H); 13C NMR (125
MHz, CDCl3): 141.6, 139.3, 134.6, 128.5, 127.5, 83.3, 41.3, 31.5, 29.1,
24.5, 22.6, 14.1, -2.1; 11B NMR (160 MHz, CDCl3): 30.1; HRMS (ESI-
Orbit trap) m/z: [M+H]+ calcd for C26H37BO2Si+H, 421.2734; found
421.2727.
Ethyl 2,3-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-2-enoate
1
(20a): Ζ-isomer: H NMR (500 MHz, CDCl3): 4.18 (q, J = 7.0 Hz, 2H),
2.04 (s, 3H), 1.30 (s, 12H), 1.28 (s, 12H), 1.26 (t, J = 7.0 Hz, 6H); 13C
NMR (125 MHz, CDCl3): 168.8, 84.2, 84.0, 60.0, 24.8, 24.7, 19.3, 14.3. E-
1
isomer34: H NMR (500 MHz, CDCl3): 4.24 (q, J = 7.0 Hz, 2H), 2.06 (s,
(E)-(2-Cyclopropyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
3H), 1.29 (s, 12H), 1.27 (s, 12H), 1.27 (t, J = 7.0 Hz, 6H); 13C NMR (125
MHz, CDCl3): 173.0, 83.4, 82.9, 61.8, 24.8, 24.6, 19.9, 14.0; 11B NMR
(160 MHz, CDCl3): 30.0.
yl)vinyl)(methyl)diphenylsilane (6c): H NMR (500 MHz, CDCl3): 7.55-
1
7.51 (m, 4H), 7.323-7.28 (m, 6H), 6.39 (s, 1H), 0.95 (s, 12H), 0.73 (s, 3H);
13C NMR (125 MHz, CDCl3): 139.3, 135.9, 134.6, 128.5, 127.5, 83.4, 24.6,
19.9, 8.6, -2.1; 11B NMR (160 MHz, CDCl3): 30.0; HRMS (ESI-Orbit trap)
m/z: [M+H]+ calcd for C24H31BO2Si+H, 391.2265; found 391.2261.
(E)-(3-Cyclohexyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)prop-
General procedure for the Au/TiO2-catalyzed indirect silaboration of
alkynes: To a vial containing bis(pinacolato)diboron (0.3 mmol), and the
-disilane (0.3 mmol) in 1 mL dry benzene are added 40 mg of Au/TiO2
o
(1.0 mol% in Au) and the alkyne (0.21 mmol). After heating to 65 C for 2
1-en-1-yl)dimethyl(phenyl)silane (7b)29c 1H NMR (500 MHz, CDCl3):
:
h, the reaction is complete (TLC, GC-MS). The slurry is filtered with the
aid of DCM under a low pressure through a short pad of silica gel or celite,
and the filtrate is evaporated. The residue is purified by flash column
chromatography to afford the silaboration products.
7.56-7.53 (m, 2H), 7.33-7.30 (m, 3H), 6.37 (s, 1H), 2.17 (dd, J1 = 7.0 Hz, J2
= 1.0 Hz, 2H), 1.72-1.15 (m, 11H), 1.11 (s, 12H), 0.40 (s, 6H); 13C NMR
(125 MHz, CDCl3): 145.3, 141.3, 133.8, 128.3, 127.4, 83.2, 49.5, 37.9, 33.2,
26.7, 26.4, 24.7, -0.6.
Spectroscopic data of silaboration products
(E)-(3-Cyclohexyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)prop-
1-en-1-yl)(methyl)diphenylsilane (7c): 1H NMR (300 MHz, CDCl3): 7.56-
7.27 (m, 10H), 6.54 (s, 1H), 2.23 (d, J = 7.0 Hz, 2H), 1.73-1.16 (m, 11H),
0.95 (s, 12H), 0.76 (s, 3H); 13C NMR (75 MHz, CDCl3): 143.1, 139.4,
134.6, 128.5, 127.5, 83.2, 49.5, 37.9, 33.2, 26.6, 26.4, 24.5, -2.1; 11B NMR
(160 MHz, CDCl3): 30.1; HRMS (ESI-Orbit trap) m/z: [M+H]+
C28H39BO2Si+H, 447.2891; found 447.2885.
The spectroscopic data of silaboration adducts 1b, 2b, 4b, 5b, 6b and 8b,
have been reported earlier by our group (reference 10).
(E)-Dimethyl(phenyl)(2-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)vinyl)silane (1b)29c: 1H NMR (500 MHz, CDCl3): 7.62-
7.60 (m, 2H), 7.46 (br d, J = 7.5 Hz, 2H), 7.36-7.30 (m, 5H), 7.24 (t, J = 7.5
Hz, 1H), 6.89 (s, 1H), 1.18 (s, 12H), 0.51 (s, 6H); 13C NMR (125 MHz,
CDCl3): 147.6, 145.3, 140.5, 133.9, 128.5, 128.0, 127.6, 127.0, 127.0, 83.8,
24.8, -0.6.
(E)-(2-Cyclohexyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
1
yl)vinyl)trimethylsilane (8d): H NMR (500 MHz, CDCl3): 6.20 (s, 1H),
(E)-Methyldiphenyl(2-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-
2.14-2.09 (m, 1H), 1.75-1.12 (m, 10H), 1.28 (s, 12H), 0.11 (s, 9H); 13C
NMR (125 MHz, CDCl3): 141.8, 83.2, 47.7, 32.6, 26.8, 26.4, 25.1, 0.4; 11B
NMR (160 MHz, CDCl3): 30.4; HRMS (ESI-Orbit trap) m/z: [M+H]+ calcd
for C17H33BO2Si+H, 309.2421; found 309.2416.
1
dioxaborolan-2-yl)vinyl)silane (1c): H NMR (500 MHz, CDCl3): 7.64-
7.30 (m, 15H), 7.09 (br s, 1H), 1.03 (s, 12H), 0.88 (s, 3H); 13C NMR (125
MHz, CDCl3): 145.3, 144.9, 138.7, 134.6, 128.8, 128.1, 127.7, 127.2, 127.0,
Submitted to the European Journal of Organic Chemistry
5
This article is protected by copyright. All rights reserved.